Skip navigation
Search
Sciety application settings
Home
Groups
Explore
Newsletter
About
Log In
Sign Up
Novel dual inhibitor targeting CDC25 and HDAC for treating triple-negative breast cancer
Bidyadhar Sethy
Richa Upadhyay
Iin Narwanti
Zih-Yao Yu
Sung-Bau Lee
Jing-Ping Liou
Read the full article
See related articles
Listed in
This article is not in any list yet, why not save it to one of your lists.
Log in to save this article
Abstract
No abstract available
Article activity feed
Version published to 10.1007/s10495-024-02023-7
Oct 12, 2024
Version published to 10.21203/rs.3.rs-4661784/v1 on Research Square
Jul 24, 2024
Related articles
Advances in CDK4/6 Inhibitors: Transforming Breast Cancer Treatment
This article has 6 authors:
Sonia Santander Ballestín
María Abadía Labena
Ana Avedillo-Salas
Cristina Marco Continente
Marina Arribas Blázquez
María José Luesma Bartolomçe
Efficacy of a New Selective Indole-based Histone Deacetylase 10 Inhibitor in Targeted Anticancer Therapy
This article has 9 authors:
Amer H. Tarawneh
Salah A. Al-Trawneh
Talha Z. Yesiloglu
Matthes Zessin
Dina Robaa
Cyril Barinka
Mike Schutkowski
Wolfgang Sippl
Samir A. Ross
BUB1 Inhibition Induces Ferroptosis in Triple- Negative Breast Cancer Cell Lines
This article has 6 authors:
Sushmitha Sriramulu
Shivani Thoidingjam
Stephen L. Brown
Farzan Siddiqui
Benjamin Movsas
Shyam Nyati
Site navigation links
Home
Groups
Explore
Newsletter
About
Log In
Sign Up